跳至主要内容
临床试验/NCT03963479
NCT03963479Unknown2 期

Vitamin B6 and Magnesium on Neurobehavioral Status of Autism Spectrum Disorder: A Randomized, Double-Blind, Placebo Controlled Study

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2019年1月1日最近更新:
适应症

试验速览

阶段
2 期
发起方
入组人数
50
试验地点
2
主要终点
Autism Spectrum Disorder

研究概览

简要总结

To determine whether Vitamin B6 and Magnesium improve neurobehavioral status in terms of General observation, Cognitive working, Socialization, Communication and Sensory Dysfunction in patient with Autism Spectrum Disorder.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
2 Years 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Children between 2 to 12 years of age suspected ASD assessed by DSM-5 and ADCL tool
  • Each patient will be free of psychoactive medication for atleast 3 months prior to the entry into the trial
  • Newly diagnosed patient
  • Co-morbid neurological disorder like hyperactivity

排除标准

  • Patients with chronic diseases or any known metabolic or hormonal diseases
  • Patients with any known chromosomal or genetic syndromes
  • Patients unable to give informed consent
  • Patients unable to travel to clinical visits or non co-operative

结局指标

主要结局

Autism Spectrum Disorder

时间窗: 3 months

General observation, Cognitive Working, socialization, Communication, Sensory Dysfunction. At first a autism will be diagnosed by DSM-5 .Then the above mention criterias along with the severity will be diagnosed by Autism Diagnostic Checklist tool by a psychologist.

次要结局

  • Autism Spectrum Disorder(0 month)

研究者

发起方
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Farhana Khan

Resident

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

研究点 (2)

Loading locations...

相似试验